Essex Bio-Technology Limited
HKEX:1061.HK
2.59 (HKD) • At close November 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Essex Bio-Technology Limited |
Symbool | 1061.HK |
Munteenheid | HKD |
Prijs | 2.59 |
Beurswaarde | 1,469,462,400 |
Dividendpercentage | 2.79% |
52-weken bereik | 1.96 - 3.1 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Mia Je Ngiam B.Sc. |
Website | https://www.essexbio.com |
An error occurred while fetching data.
Over Essex Bio-Technology Limited
Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)